Tobam Regeneron Pharmaceuticals, Inc. Transaction History

Tobam

$638 Million
Q2 2024

A detailed history of Tobam transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tobam holds 1,058 shares of REGN stock, worth $1.11 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,058

Previous 1,058 -0.0%

Holding current value

$1.11 Million

Previous $1.11 Million -0.0%

% of portfolio

0.17%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$883.2 - $1071.19 $2.22 Million - $2.7 Million	-2,517 Reduced 70.41%	1,058 $1.11 Million
Q1 2024 May 02, 2024	SELL	$902.69 - $993.35 $892,760 - $982,423	-989 Reduced 21.67%	3,575 $3.44 Million
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $565,881 - $643,641	-730 Reduced 13.79%	4,564 $4.01 Million
Q3 2023 Oct 31, 2023	SELL	$692.45 - $844.37 $1.57 Million - $1.92 Million	-2,274 Reduced 30.05%	5,294 $4.36 Million
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $5.01 Million - $5.95 Million	-7,161 Reduced 48.62%	7,568 $5.44 Million
Q1 2023 May 03, 2023	SELL	$680.49 - $826.97 $3.8 Million - $4.61 Million	-5,577 Reduced 27.46%	14,729 $12.1 Million
Q4 2022 Feb 02, 2023	BUY	$705.89 - $766.39 $4.41 Million - $4.79 Million	6,251 Added 44.48%	20,306 $14.7 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $2.27 Million - $2.87 Million	-3,959 Reduced 21.98%	14,055 $9.68 Million
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $10.2 Million - $13.8 Million	-18,663 Reduced 50.88%	18,014 $10.6 Million
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $881,372 - $1.03 Million	1,481 Added 4.21%	36,677 $25.6 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $5.28 Million - $6.52 Million	-9,721 Reduced 21.64%	35,196 $22.2 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $1.43 Million - $1.7 Million	2,499 Added 5.89%	44,917 $27.2 Million
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $555,067 - $655,725	-1,174 Reduced 2.69%	42,418 $23.7 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $111,235 - $136,501	249 Added 0.57%	43,592 $20.6 Million
Q4 2020 Feb 03, 2021	BUY	$478.3 - $607.98 $1.44 Million - $1.82 Million	3,001 Added 7.44%	43,343 $20.9 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $7.72 Million - $9.33 Million	14,174 Added 54.17%	40,342 $22.6 Million
Q2 2020 Aug 17, 2020	BUY	$493.32 - $643.92 $11.9 Million - $15.5 Million	24,054 Added 1137.84%	26,168 $16.3 Million
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $710,684 - $1.05 Million	2,114 New	2,114 $1.03 Million
Q4 2018 Feb 11, 2019	SELL	$335.82 - $403.04 $16 Million - $19.2 Million	-47,719 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$351.14 - $408.51 $2.71 Million - $3.15 Million	7,716 Added 19.29%	47,719 $19.3 Million
Q2 2018 Aug 03, 2018	BUY	$284.6 - $344.99 $1.66 Million - $2.01 Million	5,816 Added 17.01%	40,003 $13.8 Million
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $9.19 Million - $11.5 Million	29,095 Added 571.39%	34,187 $11.8 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $1.83 Million - $2.39 Million	5,092	5,092 $1.91 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account